Expertise in
36
conditions

Dr. Dinesh Khanna

Internal Medicine
1580 Santa Barbara Blvd Ste C, 
The Villages, FL 
Accepting New Patients
24 Years of Experience
Before you request
Expertise in
36
conditions
1580 Santa Barbara Blvd Ste C, 
The Villages, FL 

Overview

Dinesh Khanna is a primary care provider, practicing in Internal Medicine in The Villages, Florida. He has been practicing medicine for over 24 years.

Dr. Khanna is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Systemic Sclerosis (SSc), Scleroderma, Interstitial Lung Disease, Acute Interstitial Pneumonia, and Lung Transplant.

Dr. Khanna is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 494 peer reviewed articles and participating in 8 clinical trials. Dr. Khanna is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in FL

Board Certifications

American Board Of Internal Medicine

Languages Spoken

English
Hindi
Urdu

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Geisinger
  • HMO
  • POS
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Premier Medical Associates
1580 Santa Barbara Blvd Ste C, The Villages, FL 32159

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Booster Effects With Autoimmune Treatments in Patients With Poor Response to Initial COVID-19 Vaccine (ACV01)
Booster Effects With Autoimmune Treatments in Patients With Poor Response to Initial COVID-19 Vaccine (ACV01)
Enrollment Status: Terminated
Publish Date: June 10, 2026
Intervention Type: Drug, Biological
Study Drugs: Moderna mRNA-1273, BNT162b2, Ad26.COV2.S, IS (MMF or MPA), IS (MTX), IS (B cell Depletion Therapy)
Study Phase: Phase 2
Evaluation of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis BRAVOS: A Phase 1/2 Multicenter Randomized, Double Blinded, Safety Study (ITN075AI)
Evaluation of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis BRAVOS: A Phase 1/2 Multicenter Randomized, Double Blinded, Safety Study (ITN075AI)
Enrollment Status: Completed
Publish Date: May 05, 2026
Intervention Type: Biological
Study Drug: Brentuximab vedotin
Study Phase: Phase 1/Phase 2
A Phase II Multi-center Study of High-Dose Cyclophosphamide and Antithymocyte Globulin Followed by Autologous Hematopoietic Cell Transplantation With Post Transplant Maintenance for the Treatment of Systemic Sclerosis
A Phase II Multi-center Study of High-Dose Cyclophosphamide and Antithymocyte Globulin Followed by Autologous Hematopoietic Cell Transplantation With Post Transplant Maintenance for the Treatment of Systemic Sclerosis
Enrollment Status: Completed
Publish Date: January 07, 2025
Intervention Type: Other, Drug, Biological, Procedure
Study Drugs: Anti-thymocyte globulin, Cyclophosphamide, Filgrastim, Mycophenolate mofetil, Plerixafor
Study Phase: Phase 2
Patient-Reported Outcomes Measurement Information System Integration Into Rheumatology Clinical Practice
Patient-Reported Outcomes Measurement Information System Integration Into Rheumatology Clinical Practice
Enrollment Status: Completed
Publish Date: April 30, 2024
Intervention Type: Behavioral
Study Phase: Not Applicable
Curcumin in Rheumatoid Arthritis - ACross-Over Pilot Study
Curcumin in Rheumatoid Arthritis - ACross-Over Pilot Study
Enrollment Status: Completed
Publish Date: September 29, 2023
Intervention Type: Drug
Study Drug: Curcumin (Longvida™)
Study Phase: Early Phase 1
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Other, Biological, Drug, Diagnostic test
Study Phase: Phase 2
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Enrollment Status: Completed
Publish Date: February 17, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Multi-center Randomized, Double Blind, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Riociguat in Scleroderma - Associated Digital Ulcers
A Multi-center Randomized, Double Blind, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Riociguat in Scleroderma - Associated Digital Ulcers
Enrollment Status: Completed
Publish Date: September 24, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

494 Total Publications

Navigating evidence-based recommendations for the management of systemic sclerosis.
Navigating evidence-based recommendations for the management of systemic sclerosis.
Journal: Nature reviews. Rheumatology
Published: July 16, 2026
Similar Doctors
Expertise in
111
conditions
Dr. Florian Gegaj
Internal Medicine
Expertise in
111
conditions
Dr. Florian Gegaj
Internal Medicine
Before you request

Office

1050 Old Camp Rd Ste 206, 
The Villages, FL 
 (5.7 miles away)
352-353-0092
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Florian Gegaj is a primary care provider, practicing in Internal Medicine in The Villages, Florida. Dr. Gegaj is highly rated in 111 conditions, according to our data. His clinical expertise encompasses Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and High Cholesterol. Dr. Gegaj is currently accepting new patients.

Expertise in
74
conditions
Dr. Ana K. Vuchidolov
Internal Medicine
Expertise in
74
conditions
Dr. Ana K. Vuchidolov
Internal Medicine

Quality Physician Group PLLC

5455 Spencer Ct # 1, 
Wildwood, FL 
 (10.9 miles away)
352-365-1224
Experience:
18+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ana Vuchidolov is a primary care provider, practicing in Internal Medicine in Wildwood, Florida. She has been practicing medicine for over 18 years. Dr. Vuchidolov is highly rated in 74 conditions, according to our data. Her clinical expertise encompasses High Cholesterol, Menopause, Cirrhosis, and Familial Combined Hyperlipidemia. Dr. Vuchidolov is board certified in American Board Of Internal Medicine.

Expertise in
61
conditions
Dr. Ravi P. Gupta
Internal Medicine
Expertise in
61
conditions
Dr. Ravi P. Gupta
Internal Medicine

Mid-Florida Primary Care, PA

401 W North Blvd, 
Leesburg, FL 
 (8.2 miles away)
352-728-4242
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients

Ravi Gupta is a primary care provider, practicing in Internal Medicine in Leesburg, Florida. Dr. Gupta is highly rated in 61 conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Pulmonary Edema, Anemia, and Cardiac Ablation. Dr. Gupta is board certified in American Board Of Internal Medicine. Dr. Gupta is currently accepting new patients.

Frequently Asked Questions about Dr. Dinesh Khanna

How do I make an appointment with Dr. Dinesh Khanna?

You can book an appointment with Dr. Dinesh Khanna by calling their office at 352-259-2159. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Dinesh Khanna a top-rated expert for Systemic Sclerosis (SSc)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Dinesh Khanna is classified as an Elite expert for Systemic Sclerosis (SSc), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Dinesh Khanna specialize in?

While Dr. Dinesh Khanna is a Internal Medicine, they have specific expertise in Systemic Sclerosis (SSc), Scleroderma, and Interstitial Lung Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Dinesh Khanna participate in research or clinical trials?

Yes. Dr. Dinesh Khanna has published 494 articles and abstracts on conditions like Systemic Sclerosis (SSc). You can view a list of Dr. Dinesh Khanna's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Dinesh Khanna accept my insurance?

Dr. Dinesh Khanna accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 352-259-2159 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Khanna's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 21 Advanced Conditions
View All 99 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile